GeneralBullishBlockonomi · 3h ago6/10
📰
SciSparc Ltd. (SPRC) Stock Explodes 202% Following NeuroThera’s TSX Exchange Milestone
SciSparc's stock surged 202% following conditional TSX approval for its subsidiary NeuroThera's $9.46M acquisition of CliniQuantum. The milestone represents a significant step forward for the biotech company's exchange listing ambitions and strategic expansion in the healthcare technology sector.